I love Kirk's continued buying over the years . . . . . especially the 7.4M shares he bought last June at $13.37 to enable the sale of the $200M convertible note . . . .. . and the $20 -$25M he spent this spring . . . . .. . but with the star quality of his Board of Directors . . .. . these people should be buying the stock on the open market to send a clear signal to the Street and XON shareholders that they too believe XON has a bright future. At a minimum Kirk should eliminate the cash portion of their compensation and make it all common stock.
If Kirk went out of his way to solicit some institutional buyers of the stock now . . . . while it is still cheap . . . . . "if" Helen hits the cover off the ball in 3 months at the next CC . . . . a lot more stock would be in "strong hands" . . . . .and that will make it a lot more interesting as the company makes progress going forward.
Kirk said the following on the August 8, 2019 CC :
"Three months from now, Dr. Sabzevari will be here and she will really be the star of the show. We'll want to talk about our data at that time. Right now, even though I will tell you that we're very excited about everything that's going on at Precigen, we're just not going to talk about any more data than Dr. Sabzevari already has released. "
Between now and November 8, 2019, . . . . probably the date of the next CC, . . .. I would think we might see some buying in the stock . . . .. especially "if" the word gets out that things are going well for Dr. S.
PS Note the highlighted "ifs" to make sure I don't get Mabel to excited :)